Muhammad Usama Younas

Muhammad Usama Younas

Auto-generated profile, based on publicly available information

Muhammad Usama Younas

Department of Medicine King Edward Medical University Lahore Punjab Pakistan

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 November 2025 in Health Science Reports
Verified
Journal Article
Open access
MIMuhammad Mustafa Imran
Muhammad Mustafa Imran
AKAbdul Rehman Shahid Khan
Abdul Rehman Shahid Khan
MYMuhammad Usama Younas
Muhammad Usama Younas
YGYashika Gupta
Yashika Gupta
RBRoma Bai
Roma Bai
MHMuhammad Haseeb
Muhammad Haseeb
Background and Aims: Hughes‐Stovin Syndrome (HSS) is an extremely rare vasculitic disorder characterized by a combination of pulmonary artery aneurysms and deep venous thrombosis (DVT). Often considered a variant or incomplete form of Behçet's disease (BD), it presents diagnostic and therapeutic challenges due to its overlap with other conditions and the lack of standardized criteria. This narrative review aims to describe the epidemiology, pathophysiology, clinical presentation, diagnostic process, treatment strategies, and clinical outcomes associated with HSS. Methods: A narrative review of the literature was conducted using PubMed and Google Scholar. The search included the terms “HSS” OR “pulmonary artery aneurysm” AND “Behçet's disease.” Relevant literature was selected for inclusion based on thematic relevance and clinical importance. Only English‐language articles focusing on human subjects were included, with an emphasis on case reports, series, reviews, and expert opinions. Literature on Behçet's disease was also reviewed for comparative purposes. The reference lists of key articles were manually searched for additional sources. No publication date restrictions were applied. The final search was completed on April 6, 2025. Results: Fewer than 100 cases of HSS have been published in the English‐language literature to date. It primarily affects young adult males and typically presents with hemoptysis, chest pain, and venous thrombosis. Diagnosis is clinical and radiological, with CTPA being the preferred imaging modality. Immunosuppressive therapy remains the cornerstone of management, though there is no consensus on treatment protocols. The use of anticoagulation is controversial due to the risk of aneurysmal rupture. Conclusions: HSS presents significant diagnostic and therapeutic challenges due to its rarity and clinical overlap with other vasculitides. Bridging the current gaps in clinical knowledge will require global collaboration to establish consistent diagnostic standards, deepen our understanding of its underlying mechanisms, and develop evidence‐based treatment protocols.

1 January 2024 in Journal of Interventional Cardiology
Verified
Journal Article
Open access
ZMZuhair Majeed
Zuhair Majeed
MTMuhammad Haider Tariq
Muhammad Haider Tariq
AAArslan Ahmed
Arslan Ahmed
MUMuhammad Usama
Muhammad Usama
AAAhmed Mazen Amin
Ahmed Mazen Amin
UKUbaid Khan
Ubaid Khan
Introduction: The sheathless transradial (TR) technique is a novel approach that may offer potential benefits over the conventional TR approach. We aim to comprehensively investigate the safety and efficacy of sheathless versus conventional TR percutaneous coronary interventions (PCIs).Methods: We conducted comprehensive searches across PubMed, CENTRAL, Web of Science (WOS), Scopus, and EMBASE until July 2023. Pooled data were reported using risk ratio (RR) for dichotomous outcomes and mean difference (MD) for continuous outcomes, along with a 95% confidence interval (CI). PROSPERO ID: CRD42023443834.Results: We included 11 studies with 15,392 patients. The radial artery spasm (RAS) (RR: 0.26, 95% CI: [0.09, 0.77], p = 0.02) and cross‐over to the femoral site (RR: 0.28, 95% CI: [0.10, 0.81], p = 0.02) were significantly lower in the sheathless group. However, radial artery occlusion (RAO) (RR: 2.84, 95% CI: [1.78, 4.54], p < 0.0001) and success rate (RR: 1.011, 95% CI: [1.004, 1.019], p = 0.002) were significantly higher in the sheathless group. Also, we did not find a significant difference between both groups in all‐cause mortality (RR: 0.41, 95% CI: [0.16, 1.04], p = 0.06).Conclusion: The sheathless TR approach showed lower rates of RAS and femoral conversion. Sheathless has a higher success rate; however, it also increased RAO. Thus, more trials are needed to confirm this technique’s long‐term outcomes and complications.